Navi Pharmaceuticals Private Limited
About Navi Pharmaceuticals Private Limited
Data last updated:
Navi Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 02 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33127DL2016PTC305358. Its GSTIN is 07AAFCN3400M1ZJ (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sufyan Ali and Mohd Naved.
Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at H.No.448 Ground Floor Jaitpur Extention – II Badarpur, New Delhi, Delhi, India – 110044.
As per the financials filed for FY 2020, the company reported a revenue of ₹6.11 Lakh, a decline of 61% compared to the previous year. For the same year it recorded a net profit of ₹19,987 (net margin 3.3%) and EBITDA of ₹31,839 (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 32% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Navi Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH.No.448 Ground Floor Jaitpur Extention – II Badarpur, New Delhi, Delhi, India – 110044
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Navi Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Navi Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Navi Pharmaceuticals Private Limited, buy the company report.
Financials of Navi Pharmaceuticals Private Limited
FY 2020 filings availableNavi Pharmaceuticals Private Limited reported revenue of ₹6.11 Lakh (down 61% YoY) for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue fell 61% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 32%. EBITDA rose 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹31,839 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹19,987 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 5.2% | |||
| Net Profit Margin | 3.3% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Navi Pharmaceuticals Private Limited, buy the company report.
Board of directors of Navi Pharmaceuticals Private Limited
Navi Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sufyan Ali | Director | 02 Sep 2016 | 10 Years 1 Months | Current |
| Mohd Naved Also directs: Navi Constructions and Builders LLP | Director | 02 Sep 2016 | 10 Years 1 Months | Current |
Peer comparison
Navi Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Rossland Pharmaceuticals Private Limited | ₹6.15 Lakh (FY 2025) | 9.0% | New Delhi, Delhi, India | |||
| Mediseth Medicare Pharmaceuticals Private Limited | ₹6.13 Lakh (FY 2024) | 85.0% | Gurugram, Haryana, India | |||
| Ambid Pharmaceuticals Private Limited | ₹6.13 Lakh (FY 2025) | -68.0% | Patna, Bihar, India | |||
| Lords Pharmaceuticals Private Limited | ₹6.12 Lakh (FY 2022) | Bhubaneshwar, Odisha, India | ||||
| Navi Pharmaceuticals Private Limitedthis company | ₹6.11 Lakh (FY 2020) | ₹19,987 | 3.3% | -61.0% | New Delhi, Delhi, India | |
| Wyenne Davis Pharmaceuticals Private Limited | ₹6.1 Lakh (FY 2025) | 34.0% | Palakkad, Kerala, India |
To see the full peer comparison of Navi Pharmaceuticals Private Limited, buy the company report.
Auditor
Navi Pharmaceuticals Private Limited is audited by HARNEDRA P SINGH & CO. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARNEDRA P SINGH & CO. | FY 2017 | 531428 |
Shareholding
The shareholding of Navi Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Navi Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Navi Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Navi Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Navi Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAFCN3400M1ZJ | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Navi Pharmaceuticals Private Limited, buy the company report.
Recent activity
Navi Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Mohd Naved was appointed as Director on 02 Sep 2016.
Frequently asked questions
Navi Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 02 September 2016 (10+ years old) and is registered under CIN U33127DL2016PTC305358.
Navi Pharmaceuticals has 2 current directors:
- Sufyan Ali - Director
- Mohd Naved - Director
The latest financial statements of Navi Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 31 December 2020. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Navi Pharmaceuticals is 07AAFCN3400M1ZJ, registered in Delhi.
The CIN (Corporate Identification Number) of Navi Pharmaceuticals is U33127DL2016PTC305358. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Navi Pharmaceuticals was incorporated on 02 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Navi Pharmaceuticals by revenue are Rossland Pharmaceuticals Private Limited, Mediseth Medicare Pharmaceuticals Private Limited, Ambid Pharmaceuticals Private Limited, Lords Pharmaceuticals Private Limited, Wyenne Davis Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohd Naved was appointed as Director on 02 Sep 2016. Sufyan Ali was appointed as Director on 02 Sep 2016.
The registered office of Navi Pharmaceuticals is at H.No.448 Ground Floor Jaitpur Extention – II Badarpur, New Delhi, Delhi, India – 110044.
Navi Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Navi Pharmaceuticals is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
